Paper6133417
Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation.
Folk JE. Adv Enzymol Relat Areas Mol Biol, 1983. Cited by 263 papers, by iCite.
Cite this record
ConductScience Library. Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation. Papers, record 6133417. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6133417
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mechanism and basis for specificity of transglutaminase-catalyzed epsilon-(gamma-glutamyl) lysine bond formation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyltransferases | Major topic |
| Dipeptides | Major topic |
| Amides | |
| Animals | |
| Binding Sites | |
| Factor XIII | |
| Guinea Pigs | |
| Humans | |
| Kinetics | |
| Liver | |
| Substrate Specificity | |
| Transglutaminases |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42533401 | Beyond Sequence: Posttranslational Remodeling of Antigens in Autoimmunity. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42533401 | PubMed |
| 42087096 | Beyond neurotransmission: the roles of serotonylation in physiological and pathological processes. | Cell Mol Biol Lett | 2026 | https://conductscience.org/library/papers/42087096 | PubMed |
| 41490984 | Targeting the Primordial Chaperone to Overcome Acquired Drug Resistance in Cancer: TG2-Mediated Autophagy. | Biomol Ther (Seoul) | 2026 | https://conductscience.org/library/papers/41490984 | PubMed |
| 41129518 | Efficient two-step chemoenzymatic conjugation of antibody fragments with reporter compounds by a specific thiol-PEG-amine Linker, HS-PEG-NH2. | PLoS One | 2025 | https://conductscience.org/library/papers/41129518 | PubMed |
| 35642005 | Ethacrynic acid is an inhibitor of human factor XIIIa. | BMC Pharmacol Toxicol | 2022 | https://conductscience.org/library/papers/35642005 | PubMed |
| 32708896 | Transglutaminase 2-Mediated p53 Depletion Promotes Angiogenesis by Increasing HIF-1α-p300 Binding in Renal Cell Carcinoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32708896 | PubMed |
| 32560270 | Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma. | Cells | 2020 | https://conductscience.org/library/papers/32560270 | PubMed |
| 32548124 | Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease. | Front Nutr | 2020 | https://conductscience.org/library/papers/32548124 | PubMed |
| 32502864 | Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism. | Eur J Med Chem | 2020 | https://conductscience.org/library/papers/32502864 | PubMed |
| 32367038 | Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides. | Sci Rep | 2020 | https://conductscience.org/library/papers/32367038 | PubMed |
| 31407850 | Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A. | FEBS J | 2020 | https://conductscience.org/library/papers/31407850 | PubMed |
| 30761263 | Optimised methods (SDS/PAGE and LC-MS) reveal deamidation in all examined transglutaminase-mediated reactions. | FEBS Open Bio | 2019 | https://conductscience.org/library/papers/30761263 | PubMed |
| 30229425 | Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation. | Cerebellum | 2019 | https://conductscience.org/library/papers/30229425 | PubMed |
| 29362136 | The diamond anniversary of tissue transglutaminase: a protein of many talents. | Drug Discov Today | 2018 | https://conductscience.org/library/papers/29362136 | PubMed |
| 27784785 | Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27784785 | PubMed |
| 24888439 | Dihydroisoxazole inhibitors of Anopheles gambiae seminal transglutaminase AgTG3. | Malar J | 2014 | https://conductscience.org/library/papers/24888439 | PubMed |
| 24351005 | Injectable gel graft for bone defect repair. | Regen Med | 2014 | https://conductscience.org/library/papers/24351005 | PubMed |
| 23288850 | Characterization of Anopheles gambiae transglutaminase 3 (AgTG3) and its native substrate Plugin. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23288850 | PubMed |
| 23193435 | Transglutaminase inhibition: A therapy to protect cells from death in neurodegeneration? | World J Biol Chem | 2012 | https://conductscience.org/library/papers/23193435 | PubMed |
| 22606367 | Celiac disease, inflammation and oxidative damage: a nutrigenetic approach. | Nutrients | 2012 | https://conductscience.org/library/papers/22606367 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6133417
GET https://conductscience.org/api/papers/v1/6133417/cited_by?page=2